4//SEC Filing
Hernday Natasha 4
Accession 0001626199-24-000013
CIK 0001626199other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 7:06 PM ET
Size
5.7 KB
Accession
0001626199-24-000013
Insider Transaction Report
Form 4
Hernday Natasha
Director
Transactions
- Award
Stock Option (Right to buy)
2024-01-02+17,500→ 17,500 totalExercise: $19.00Exp: 2034-01-01→ Common Stock (17,500 underlying)
Footnotes (2)
- [F1]The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant.
- [F2]1/12th of the shares subject to the option become vested and exercisable on February 2, 2024 and 1/12 of the shares subject to the option shall vest monthly thereafter.
Documents
Issuer
ALPINE IMMUNE SCIENCES, INC.
CIK 0001626199
Entity typeother
Related Parties
1- filerCIK 0001780547
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 7:06 PM ET
- Size
- 5.7 KB